PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: BCM-PAN-11

Model Contact
Model: BCM-PAN-11
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-PAN-11

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)

GeneChrStartEndRefAltcDNA ChangeCodon ChangeProtein ChangeTVAF Gene Mutation Freq. Site Mutation Freq.Most Severe EffectAll EffectsMutation ImpactTranscript IDClinVar Clinical SignificanceCOSMIC IDgnomAD Non-Cancer AFdbSNP IDGene Mutation Freq.Site Mutation Freq.Transcript IDClinVar Clinical SignificanceCOSMIC IDdbSNP ID
APCchr5112841059112841059TAc.5465T>AgTc/gAcp.V1822D0.98761Missense VariantMissense VariantMODERATEENST00000257430.9
Benign
COSV57321643
0.794920000000rs459552
61ENST00000257430.9BenignCOSV57321643rs459552
ARchrX6754651467546526TGGCGGCGGCGGCTc.1409_1420delGGCGGCGGCGGC/-p.G470_G473del0.903172In-frame DeletionIn-frame DeletionMODERATEENST00000374690.9

COSV65964523

172ENST00000374690.9COSV65964523
ASXL2chr22574354525743545GCc.2792C>GaCt/aGtp.T931S0.53722Missense VariantMissense VariantMODERATEENST00000435504.9


0.000127792000rs200647261
22ENST00000435504.9rs200647261
ATRXchrX7768247177682471CGc.2785G>CGag/Cagp.E929Q0.9992020Missense VariantMissense VariantMODERATEENST00000373344.10
Benign

rs3088074
2020ENST00000373344.10Benignrs3088074
BARD1chr2214728810214728810TCc.2200A>GAca/Gcap.T734A0.49152Missense VariantMissense VariantMODERATEENST00000260947.9
Uncertain_significance

rs1553612113
52ENST00000260947.9Uncertain_significancers1553612113
BCRchr222329260323292603GAc.2845G>AGtc/Atcp.V949I0.4272Missense VariantMissense VariantMODERATEENST00000305877.13
Benign/Likely_benign

0.004601100000rs2229038
72ENST00000305877.13Benign/Likely_benignrs2229038
BIRC6chr23241584032415840AGc.2549A>GaAa/aGap.K850R0.34742Missense VariantMissense VariantMODERATEENST00000421745.6


0.000025373600rs772164177
42ENST00000421745.6rs772164177
BRCA2chr133235525032355250TCc.7397T>CgTa/gCap.V2466A0.98352Missense VariantMissense VariantMODERATEENST00000380152.7
Benign
COSV66451785
0.994912000000rs169547
52ENST00000380152.7BenignCOSV66451785rs169547
BRCA2chr133233292232332922CAc.1444C>ACtt/Attp.L482I0.08751Missense VariantMissense VariantMODERATEENST00000380152.7
Uncertain_significance
COSV66450724
rs587776460
51ENST00000380152.7Uncertain_significanceCOSV66450724rs587776460
CIITAchr161090907010909070AGc.2702A>GcAg/cGgp.Q901R0.9922424Missense VariantMissense VariantMODERATEENST00000618327.4
Benign

0.983235000000rs7197779
2424ENST00000618327.4Benignrs7197779
CREB3L2chr7137928167137928170CTGGCc.299_301delaCCAgt/agtp.T100del1.01010In-frame DeletionIn-frame DeletionMODERATEENST00000330387.11

COSV57791862
rs3217268
1010ENST00000330387.11COSV57791862rs3217268
CTNND2chr51139705011397050GAc.593C>TaCg/aTgp.T198M0.66722Missense VariantMissense VariantMODERATEENST00000304623.13
Likely_benign
COSV58896382
0.000038040800rs141302945
22ENST00000304623.13Likely_benignCOSV58896382rs141302945
DCCchr185234085452340854TCc.67T>CTtc/Ctcp.F23L1.065Missense VariantMissense VariantMODERATEENST00000442544.7
Benign

0.985567000000rs9951523
65ENST00000442544.7Benignrs9951523
ELNchr77405638474056384GAc.1264G>AGgt/Agtp.G422S0.26544Missense VariantMissense VariantMODERATEENST00000252034.12
Benign
COSV52708305
0.318730000000rs2071307
44ENST00000252034.12BenignCOSV52708305rs2071307
EXT1chr8118110795118110795CGc.252G>CcaG/caCp.Q84H0.48222Missense VariantMissense VariantMODERATEENST00000378204.7
Uncertain_significance

0.000008444520rs376231630
22ENST00000378204.7Uncertain_significancers376231630
CNV


Histology Information for Model: BCM-PAN-11
There are no histology images for this model.













Metastasis Information for Model: BCM-PAN-11
 
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node

Patient Treatment Information for Model: BCM-PAN-11

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseReason Stopped
10Gemcitabine, Radiation Therapy (RT)Adjuvant40.740.99106 daysProgressive DiseaseDisease Progression
20FolfoxAdjuvant41.041.31113 daysProgressive DiseaseDisease Progression













Please wait...